Protagonist Therapeutics, Inc Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
Protagonist Therapeutics, Inc (PTGX) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of -$559.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-08-05
- Protagonist Therapeutics, Inc other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-06-30 was -$559.00K.
- Protagonist Therapeutics, Inc other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-03-31 was -$910.00K, a 644.91% decline year-over-year.
- Protagonist Therapeutics, Inc other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-12-31 was $116.00K.
- Protagonist Therapeutics, Inc other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-09-30 was $540.00K, a 65.93% decline year-over-year.
- Protagonist Therapeutics, Inc other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2025 was $723.00K, a 3043.48% increase from fiscal 2024.
- Protagonist Therapeutics, Inc other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2024 was $23.00K, a 90.94% decline from fiscal 2023.
- Protagonist Therapeutics, Inc other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2023 was $254.00K.
- Protagonist Therapeutics, Inc other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2022 was -$60.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$559.00K 10-Q · filed 2026-08-05 | -$1.47M 10-Q · filed 2026-08-05 | -$1.35M derived: sum of 3 quarters · filed 2026-08-05 | -$813.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$910.00K 10-Q · filed 2026-05-05 | -$794.00K derived: sum of 2 quarters · filed 2026-05-05 | -$254.00K derived: sum of 3 quarters · filed 2026-05-05 | -$354.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $116.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $656.00K derived: sum of 2 quarters · filed 2026-02-25 | $556.00K derived: sum of 3 quarters · filed 2026-08-05 | $723.00K 10-K · filed 2026-02-25 |
| 2025-09-30 | $540.00K 10-Q · filed 2025-11-06 | $440.00K derived: sum of 2 quarters · filed 2026-08-05 | $607.00K 10-Q · filed 2025-11-06 | -$811.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$100.00K 10-Q · filed 2026-08-05 | $67.00K 10-Q · filed 2026-08-05 | -$1.35M derived: sum of 3 quarters · filed 2026-08-05 | $234.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $167.00K 10-Q · filed 2026-05-05 | -$1.25M derived: sum of 2 quarters · filed 2026-05-05 | $334.00K derived: sum of 3 quarters · filed 2026-05-05 | $314.00K derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | -$1.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $167.00K derived: sum of 2 quarters · filed 2026-02-25 | $147.00K derived: sum of 3 quarters · filed 2026-02-25 | $23.00K 10-K · filed 2026-02-25 |
| 2024-09-30 | $1.58M 10-Q · filed 2025-11-06 | $1.56M derived: sum of 2 quarters · filed 2025-11-06 | $1.44M 10-Q · filed 2025-11-06 | $1.51M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | -$20.00K 10-Q · filed 2025-08-06 | -$144.00K 10-Q · filed 2025-08-06 | -$79.00K derived: sum of 3 quarters · filed 2026-02-25 | -$51.00K derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | -$124.00K 10-Q · filed 2025-05-06 | -$59.00K derived: sum of 2 quarters · filed 2026-02-25 | -$31.00K derived: sum of 3 quarters · filed 2026-02-25 | -$107.00K derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $65.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $93.00K derived: sum of 2 quarters · filed 2026-02-25 | $17.00K derived: sum of 3 quarters · filed 2026-02-25 | $254.00K 10-K · filed 2026-02-25 |
| 2023-09-30 | $28.00K 10-Q · filed 2024-11-07 | -$48.00K derived: sum of 2 quarters · filed 2024-11-07 | $189.00K 10-Q · filed 2024-11-07 | $310.00K derived: sum of 4 quarters · filed 2025-02-21 |
| 2023-06-30 | -$76.00K 10-Q · filed 2024-08-06 | $161.00K 10-Q · filed 2024-08-06 | $282.00K derived: sum of 3 quarters · filed 2025-02-21 | $522.00K derived: sum of 4 quarters · filed 2025-02-21 |
| 2023-03-31 | $237.00K 10-Q · filed 2024-05-07 | $358.00K derived: sum of 2 quarters · filed 2025-02-21 | $598.00K derived: sum of 3 quarters · filed 2025-02-21 | $350.00K derived: sum of 4 quarters · filed 2025-02-21 |
| 2022-12-31 | $121.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | $361.00K derived: sum of 2 quarters · filed 2025-02-21 | $113.00K derived: sum of 3 quarters · filed 2025-02-21 | -$60.00K 10-K · filed 2025-02-21 |
| 2022-09-30 | $240.00K 10-Q · filed 2023-11-02 | -$8.00K derived: sum of 2 quarters · filed 2023-11-02 | -$181.00K 10-Q · filed 2023-11-02 | -$276.00K derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | -$248.00K 10-Q · filed 2023-08-03 | -$421.00K 10-Q · filed 2023-08-03 | -$516.00K derived: sum of 3 quarters · filed 2024-02-27 | -$661.00K derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | -$173.00K 10-Q · filed 2023-05-04 | -$268.00K derived: sum of 2 quarters · filed 2024-02-27 | -$413.00K derived: sum of 3 quarters · filed 2024-02-27 | -$439.00K derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | -$95.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$240.00K derived: sum of 2 quarters · filed 2024-02-27 | -$266.00K derived: sum of 3 quarters · filed 2024-02-27 | -$327.00K 10-K · filed 2024-02-27 |
| 2021-09-30 | -$145.00K 10-Q · filed 2022-11-08 | -$171.00K derived: sum of 2 quarters · filed 2022-11-08 | -$232.00K 10-Q · filed 2022-11-08 | -$116.00K derived: sum of 4 quarters · filed 2023-03-15 |
| 2021-06-30 | -$26.00K 10-Q · filed 2022-08-04 | -$87.00K 10-Q · filed 2022-08-04 | $29.00K derived: sum of 3 quarters · filed 2023-03-15 | $149.00K derived: sum of 4 quarters · filed 2023-03-15 |
| 2021-03-31 | -$61.00K 10-Q · filed 2022-05-05 | $55.00K derived: sum of 2 quarters · filed 2023-03-15 | $175.00K derived: sum of 3 quarters · filed 2023-03-15 | -$140.00K derived: sum of 4 quarters · filed 2023-03-15 |
| 2020-12-31 | $116.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $236.00K derived: sum of 2 quarters · filed 2023-03-15 | -$79.00K derived: sum of 3 quarters · filed 2023-03-15 | $249.00K 10-K · filed 2023-03-15 |
| 2020-09-30 | $120.00K 10-Q · filed 2021-11-03 | -$195.00K derived: sum of 2 quarters · filed 2021-11-03 | $133.00K 10-Q · filed 2021-11-03 | $66.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | -$315.00K 10-Q · filed 2021-08-04 | $13.00K 10-Q · filed 2021-08-04 | -$54.00K derived: sum of 3 quarters · filed 2022-02-28 | -$41.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $328.00K 10-Q · filed 2021-05-04 | $261.00K derived: sum of 2 quarters · filed 2022-02-28 | $274.00K derived: sum of 3 quarters · filed 2022-02-28 | $296.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | -$67.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$54.00K derived: sum of 2 quarters · filed 2022-02-28 | -$32.00K derived: sum of 3 quarters · filed 2022-02-28 | $12.00K 10-K · filed 2022-02-28 |
| 2019-09-30 | $13.00K 10-Q · filed 2020-11-04 | $35.00K derived: sum of 2 quarters · filed 2020-11-04 | $79.00K 10-Q · filed 2020-11-04 | -$51.00K derived: sum of 4 quarters · filed 2021-03-10 |
| 2019-06-30 | $22.00K 10-Q · filed 2020-08-06 | $66.00K 10-Q · filed 2020-08-06 | -$64.00K derived: sum of 3 quarters · filed 2021-03-10 | -$81.00K derived: sum of 4 quarters · filed 2021-03-10 |
| 2019-03-31 | $44.00K 10-Q · filed 2020-05-07 | -$86.00K derived: sum of 2 quarters · filed 2021-03-10 | -$103.00K derived: sum of 3 quarters · filed 2021-03-10 | -$117.00K derived: sum of 4 quarters · filed 2021-03-10 |
| 2018-12-31 | -$130.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | -$147.00K derived: sum of 2 quarters · filed 2021-03-10 | -$161.00K derived: sum of 3 quarters · filed 2021-03-10 | -$227.00K 10-K · filed 2021-03-10 |
| 2018-09-30 | -$17.00K 10-Q · filed 2019-11-06 | -$31.00K derived: sum of 2 quarters · filed 2019-11-06 | -$97.00K 10-Q · filed 2019-11-06 | |
| 2018-06-30 | -$14.00K 10-Q · filed 2019-08-07 | -$80.00K 10-Q · filed 2019-08-07 | ||
| 2018-03-31 | -$66.00K 10-Q · filed 2019-05-08 | |||
| 2017-12-31 | $239.00K 10-K · filed 2020-03-10 | |||
| 2016-12-31 | -$143.00K 10-K · filed 2019-03-12 | |||
| 2015-12-31 | -$2.00K 10-K · filed 2018-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |